Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Alaunos Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +1 vs. Q2 2022
- Shares held
- 74.7M
- +1.36M (+1.8%) vs. Q2 2022
- Total value
- $128.6M
- +$37.9M (+41.7%) vs. Q2 2022
- New holders
- 20
- 35 more added
- Sold out
- 19
- 29 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $204.4K |
| Q1 2026 | 29 | $360.5K |
| Q4 2025 | 27 | $349.9K |
| Q3 2025 | 26 | $158.3K |
| Q2 2025 | 28 | $344.6K |
| Q1 2025 | 29 | $103.4K |
| Q4 2024 | 30 | $137.0K |
| Q3 2024 | 29 | $622.8K |
| Q2 2024 | 50 | $1.69M |
| Q1 2024 | 46 | $4.23M |
| Q4 2023 | 86 | $2.96M |
| Q3 2023 | 92 | $7.36M |
| Q2 2023 | 102 | $34.2M |
| Q1 2023 | 110 | $44.7M |
| Q4 2022 | 124 | $50.5M |
| Q3 2022 | 125 | $128.6M |
| Q2 2022 | 125 | $90.7M |
| Q1 2022 | 149 | $65.8M |
| Q4 2021 | 167 | $155.9M |
| Q3 2021 | 163 | $194.1M |
| Q2 2021 | 156 | $297.6M |
| Q1 2021 | 153 | $422.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Alaunos Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | 349,867 | $602.0K | 0.00% | +342,406+4,589.3% | Added |
| Federation des caisses Desjardins du Quebec | 371,539 | $639.0K | 0.01% | +63,015+20.4% | Added |
| Magnolia Capital Advisors LLC | 418,569 | $720.0K | 0.61% | +83,913+25.1% | Added |
| Two Sigma Investments, LP | 426,909 | $734.0K | 0.00% | −33,853−7.3% | Reduced |
| Northern Trust Corp | 426,592 | $734.0K | 0.00% | −3,712−0.9% | Reduced |
| Group One Trading, L.P. | 442,232 | $761.0K | 0.02% | +146,039+49.3% | Added |
| EAM Investors, LLC | 454,625 | $782.0K | 0.17% | +454,625 | New |
| Commerce Bank | 459,000 | $789.0K | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 485,434 | $835.0K | 0.03% | −451,466−48.2% | Reduced |
| Advisor Group Holdings, Inc. | 582,740 | $1.00M | 0.00% | +5,372+0.9% | Added |
| Gsa Capital Partners LLP | 608,037 | $1.05M | 0.14% | −331,177−35.3% | Reduced |
| Morgan Stanley | 746,011 | $1.28M | 0.00% | −131,030−14.9% | Reduced |
| Green Square Capital Advisors LLC | 1,080,000 | $1.86M | 0.33% | +230,500+27.1% | Added |
| Susquehanna International Group, LLP | 1,280,042 | $2.20M | 0.00% | +130,340+11.3% | Added |
| Two Sigma Advisers, LP | 1,309,492 | $2.25M | 0.01% | −641,400−32.9% | Reduced |
| Boxer Capital, LLC | 1,500,000 | $2.58M | 0.15% | +1,500,000 | New |
| Marshall Wace, LLP | 1,961,127 | $3.37M | 0.01% | +1,334,596+213.0% | Added |
| Geode Capital Management, LLC | 2,076,498 | $3.57M | 0.00% | +1,681+0.1% | Added |
| JPMorgan Chase & Co | 2,525,243 | $4.34M | 0.00% | −1,693,239−40.1% | Reduced |
| State Street Corp | 3,178,423 | $5.47M | 0.00% | +2,315,397+268.3% | Added |
| Laurion Capital Management LP | 4,220,500 | $7.26M | 0.20% | −68,693−1.6% | Reduced |
| BlackRock Inc. | 5,190,042 | $8.93M | 0.00% | −47,757−0.9% | Reduced |
| Vanguard Group Inc | 9,162,523 | $15.8M | 0.00% | −133,332−1.4% | Reduced |
| Discovery Capital Management, LLC | 14,642,959 | $25.2M | 3.94% | +517,880+3.7% | Added |
| MSD Partners, L.P. | 15,151,516 | $26.1M | 2.96% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −2,169,705−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −186,601−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −111,647−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −34,091−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −32,388−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −30,759−100.0% | Sold out |
| Pathway Financial Advisors LLC | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −25,079−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −14,275−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −10,900−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −6,750−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |
| Charter Oak Capital Management, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −1,650−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −258−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| ACG Wealth | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −491−100.0% | Sold out |
| Altium Wealth Management LLC | – | – | – | – | Not filed |